Natus Medical Issuance Purchase of Equity Shares Trend

Natus Medical Incorporated -- USA Stock  

USD 39.65  0.45  1.15%

This module enables investors to look at Natus Medical various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 42.4 M, Cost of Revenue of 152.7 M or Earning Before Interest and Taxes EBIT of 56.5 M, but also many exotic indicators such as Interest Coverage of 142, Long Term Debt to Equity of 0.1056 or Calculated Tax Rate of 30.0252. This module is a perfect complement to use when analyzing Natus Medical Valuation or Volatility. It can also complement various Natus Medical Technical models. Check also analysis of Natus Medical Correlation with competitors.
Showing smoothed Issuance Purchase of Equity Shares of Natus Medical Incorporated with missing and latest data points interpolated. A component of Net Cash Flow from Financing representing the net cash inflow (outflow) from common equity changes. Includes additional capital contributions from share issuances and exercise of stock options, and outflow from share repurchases.
Issuance Purchase of Equity Shares  10 Years Trend  
Decreasing
Slightly volatile
 Issuance Purchase of Equity Shares 
      Timeline 

Natus Medical Issuance Purchase of Equity Shares Over Time

2015-12-31 (1,267,000) 
2016-12-31 (15,659,000) 
2017-12-31 (8,908,421) 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  13,822,298
Coefficient Of Variation  240.95
Mean Deviation  22,275,567
Median  2,319,000
Standard Deviation  33,304,743
Range  117,801,000
R Value (0.59)
R Squared  0.35
Significance  0.043129
Slope (5,456,541)

Currently Trending

VDIGX   
 NAS 
Purchased over 100 shares of
2 days ago ago
Traded for 27.42
VCADX   
 NAS 
Purchased over 400 shares of
2 days ago ago
Traded for 11.77
F   
 NYQ 
Purchased over 200 shares of
2 days ago ago
Traded for 12.58